These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2198101)

  • 1. Antithrombotic therapy in the primary and secondary prevention of coronary-related death and infarction: focus on gender differences.
    Clyne CA
    Cardiology; 1990; 77 Suppl 2():99-109. PubMed ID: 2198101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombotic agents in coronary artery disease.
    Cairns JA; Théroux P; Lewis HD; Ezekowitz M; Meade TW; Sutton GC
    Chest; 1998 Nov; 114(5 Suppl):611S-633S. PubMed ID: 9822067
    [No Abstract]   [Full Text] [Related]  

  • 3. Contemporary management of coronary heart disease.
    Menown IB
    J R Coll Physicians Edinb; 2010 Mar; 40(1):44-7; quiz 48. PubMed ID: 21125040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antithrombotic therapy after myocardial infarction: arguments for the use of acetylsalicylic acid and coumarin derivatives].
    Waskowsky WM; Brouwer A; Verheugt FW
    Ned Tijdschr Geneeskd; 2005 Jan; 149(2):65-71. PubMed ID: 15688836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination antithrombotic therapy with antiplatelet agents and anticoagulants for patients with atherosclerotic heart disease.
    Arjomand H; Cohen M; Ezekowitz MD
    J Invasive Cardiol; 2004 May; 16(5):271-8. PubMed ID: 15152137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-molecular-weight heparin during instability in coronary artery disease, Fragmin during Instability in Coronary Artery Disease (FRISC) study group.
    Lancet; 1996 Mar; 347(9001):561-8. PubMed ID: 8596317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of aspirin to prevent myocardial infarction and adverse outcome during follow-up - a large series of all-comers.
    Mikkelsson J; Eskola M; Nikus K; Karhunen PJ; Niemela K
    Ann Med; 2008; 40(4):296-302. PubMed ID: 18428022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin after thrombolysis for MI.
    Seaton TL
    J Fam Pract; 1997 Mar; 44(3):249-50. PubMed ID: 9071241
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiplatelet treatment in the secondary prevention of coronary and cerebrovascular disease: is there any place for novel agents?
    Ntalas IV; Milionis HJ; Kei AA; Kalantzi KI; Goudevenos JA
    Angiology; 2014 Jul; 65(6):473-90. PubMed ID: 23966569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
    Vermeer NS; Bajorek BV
    J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Summaries for patients. Benefits and harms of warfarin plus aspirin after acute coronary events.
    Ann Intern Med; 2005 Aug; 143(4):I14. PubMed ID: 16103464
    [No Abstract]   [Full Text] [Related]  

  • 12. A cost-effectiveness analysis of aspirin versus oral anticoagulants after acute myocardial infarction in Italy -- equivalence of costs as a possible case for oral anticoagulants.
    Gianetti J; Gensini G; De Caterina R
    Thromb Haemost; 1998 Dec; 80(6):887-93. PubMed ID: 9869155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet therapy in coronary heart disease. Emerging strategies for the treatment and prevention of acute myocardial infarction.
    Becker RC
    Arch Pathol Lab Med; 1993 Jan; 117(1):89-96. PubMed ID: 8418769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antiplatelet agents--problem for cardiac surgeon].
    Bochenek A; Wilczyński M
    Kardiol Pol; 2006 Nov; 64(11):1329-31. PubMed ID: 17165174
    [No Abstract]   [Full Text] [Related]  

  • 15. Antithrombotic therapy in coronary artery disease.
    Genton E
    Adv Cardiol; 1980; 27():93-8. PubMed ID: 7446296
    [No Abstract]   [Full Text] [Related]  

  • 16. Antithrombotic therapy in acute coronary syndromes.
    Sabatine MS; Jang IK
    Acta Cardiol; 1999 Feb; 54(1):3-29. PubMed ID: 10214473
    [No Abstract]   [Full Text] [Related]  

  • 17. [Long-term antithrombotic treatment in coronary disease].
    Hodara M; Samama M
    J Mal Vasc; 1983; 8(1):28-32. PubMed ID: 6405004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.
    Sabatine MS; Cannon CP; Gibson CM; López-Sendón JL; Montalescot G; Theroux P; Claeys MJ; Cools F; Hill KA; Skene AM; McCabe CH; Braunwald E;
    N Engl J Med; 2005 Mar; 352(12):1179-89. PubMed ID: 15758000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiplatelet drugs in cardiovascular prevention: coronary events: acute phase and secondary prevention.
    Prescrire Int; 2000 Jun; 9(47):83-5. PubMed ID: 11010749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotics in atrial fibrillation and coronary disease.
    Velagapudi P; Turagam MK; Agrawal H; Mittal M; Kocheril AG; Aggarwal K
    Expert Rev Cardiovasc Ther; 2014 Aug; 12(8):977-86. PubMed ID: 25046150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.